Sophie Schaller

In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?

M. Karsdal, L. Tankó, P. Qvist, 2005, Assay and drug development technologies.

Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review

L. Tankó, P. Qvist, S. Schaller, 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment.

M. Karsdal, K. Henriksen, M. Sørensen, 2005, Drug news & perspectives.